ArticleNeuroscience applied2022
Prospects for improved prevention and treatment of neuropsychiatric disorders:
Article in Neuroscience applied, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Current Understanding and Translational Prospects of Tetrahedral Framework Nucleic Acids.JACS Au · 2025Review
- Towards precision psychiatry utilizing large-scale multimodal data paving the way for improved prevention and treatment of mental disorders.Neuroscience applied · 2023Article
- A new era for translational neuroscience.Neuroscience applied · 2022Article
- Precision psychiatry: The ultimate goal of neuroscience applied to mental health.Neuroscience applied · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Progress in Neuroscience and related fields of research is deepening our understanding of the causes and pathophysiology of neuropsychiatric disorders and opening new avenues for their improved control. Together with more refined diagnostics, this is leading to an increased focus on prevention and early intervention as well as disease-modification, as opposed to predominantly symptomatic therapy. In addition to novel psychotherapeutic and pharmacological strategies, innovative modalities of treatment are emerging, from RNA therapeutics to neurorobotics, and they are being better matched to the risk and resilience profiles, needs and desires of individual patients. Diverse aspects of this ongoing transformation will be discussed herein and related to the goals and mission of
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.